Advertisement
Screener

ANI PHARMACEUTICALS, INC (ANIP) Increase (Decrease) in Inventories

2.8 / 5 stars · 68/120 Roast Me

ANI PHARMACEUTICALS, INC Increase (Decrease) in Inventories

ANI PHARMACEUTICALS, INC (ANIP) reported Increase (Decrease) in Inventories of $132.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-07

  • ANI PHARMACEUTICALS, INC increase (decrease) in inventories for the quarter ending 2026-06-30 was -$305.00K, a 133.59% decline year-over-year.
  • ANI PHARMACEUTICALS, INC increase (decrease) in inventories for the quarter ending 2026-03-31 was $437.00K, a 30.08% decline year-over-year.
  • ANI PHARMACEUTICALS, INC increase (decrease) in inventories for the quarter ending 2025-12-31 was -$3.73M, a 652.89% decline year-over-year.
  • ANI PHARMACEUTICALS, INC increase (decrease) in inventories for the quarter ending 2025-09-30 was $8.16M, a 28.30% increase year-over-year.
  • ANI PHARMACEUTICALS, INC increase (decrease) in inventories for fiscal 2025 was $5.96M, a 72.00% decline from fiscal 2024.
  • ANI PHARMACEUTICALS, INC increase (decrease) in inventories for fiscal 2024 was $21.29M, a 264.44% increase from fiscal 2023.
  • ANI PHARMACEUTICALS, INC increase (decrease) in inventories for fiscal 2023 was $5.84M, a 75.28% decline from fiscal 2022.
  • ANI PHARMACEUTICALS, INC increase (decrease) in inventories for fiscal 2022 was $23.63M.
Period endIncrease (Decrease) in Inventories 3 monthIncrease (Decrease) in Inventories 6 monthIncrease (Decrease) in Inventories 6 month as first filedIncrease (Decrease) in Inventories 9 monthIncrease (Decrease) in Inventories 9 month as first filedIncrease (Decrease) in Inventories 12 month
2026-06-30-$305.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$132.00K
10-Q · filed 2026-08-07
-$3.60M
derived: sum of 3 quarters · filed 2026-08-07
$4.56M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$437.00K
10-Q · filed 2026-05-08
-$3.29M
derived: sum of 2 quarters · filed 2026-05-08
$4.87M
derived: sum of 3 quarters · filed 2026-05-08
$5.77M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31-$3.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$4.43M
derived: sum of 2 quarters · filed 2026-02-27
$5.34M
derived: sum of 3 quarters · filed 2026-08-07
$5.96M
10-K · filed 2026-02-27
2025-09-30$8.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$9.07M
derived: sum of 2 quarters · filed 2026-08-07
$9.69M
10-Q · filed 2025-11-07
$10.37M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$908.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$1.53M
10-Q · filed 2026-08-07
$2.21M
derived: sum of 3 quarters · filed 2026-08-07
$8.57M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31$625.00K
10-Q · filed 2026-05-08
$1.30M
derived: sum of 2 quarters · filed 2026-05-08
$7.66M
derived: sum of 3 quarters · filed 2026-05-08
$19.27M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$675.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$7.04M
derived: sum of 2 quarters · filed 2026-02-27
$18.65M
derived: sum of 3 quarters · filed 2026-02-27
$21.29M
10-K · filed 2026-02-27
2024-09-30$6.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$17.97M
derived: sum of 2 quarters · filed 2025-11-07
$20.61M
10-Q · filed 2025-11-07
$25.22M
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30$11.61M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
$14.25M
10-Q · filed 2025-08-08
$18.86M
derived: sum of 3 quarters · filed 2026-02-27
$21.13M
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31$2.64M
10-Q · filed 2025-05-09
$7.25M
derived: sum of 2 quarters · filed 2026-02-27
$9.51M
derived: sum of 3 quarters · filed 2026-02-27
$10.18M
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31$4.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$6.87M
derived: sum of 2 quarters · filed 2026-02-27
$7.54M
derived: sum of 3 quarters · filed 2026-02-27
$5.84M
10-K · filed 2026-02-27
2023-09-30$2.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08
$2.94M
derived: sum of 2 quarters · filed 2024-11-08
$1.24M
10-Q · filed 2024-11-08
$10.70M
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30$669.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
-$1.03M
10-Q · filed 2024-08-06
$8.43M
derived: sum of 3 quarters · filed 2025-02-28
$11.74M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31-$1.70M
10-Q · filed 2024-05-10
$7.76M
derived: sum of 2 quarters · filed 2025-02-28
$11.07M
derived: sum of 3 quarters · filed 2025-02-28
$20.46M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31$9.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
$12.77M
derived: sum of 2 quarters · filed 2025-02-28
$22.16M
derived: sum of 3 quarters · filed 2025-02-28
$23.63M
10-K · filed 2025-02-28
2022-09-30$3.31M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
$12.70M
derived: sum of 2 quarters · filed 2023-11-08
$14.16M
10-Q · filed 2023-11-08
$19.71M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$9.39M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$10.85M
10-Q · filed 2023-08-09
$16.40M
derived: sum of 3 quarters · filed 2024-02-29
$10.45M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$1.46M
10-Q · filed 2023-05-08
$7.01M
derived: sum of 2 quarters · filed 2024-02-29
$1.06M
derived: sum of 3 quarters · filed 2024-02-29
-$886.00K
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$5.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
-$401.00K
derived: sum of 2 quarters · filed 2024-02-29
-$2.35M
derived: sum of 3 quarters · filed 2024-02-29
-$3.22M
10-K · filed 2024-02-29
2021-09-30-$5.95M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
-$7.90M
derived: sum of 2 quarters · filed 2022-11-09
-$8.77M
10-Q · filed 2022-11-09
-$7.17M
derived: sum of 4 quarters · filed 2023-03-09
2021-06-30-$1.95M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
-$2.82M
10-Q · filed 2022-08-08
-$1.22M
derived: sum of 3 quarters · filed 2023-03-09
$3.99M
derived: sum of 4 quarters · filed 2023-03-09
2021-03-31-$876.00K
10-Q · filed 2022-05-10
$732.00K
derived: sum of 2 quarters · filed 2023-03-09
$5.94M
derived: sum of 3 quarters · filed 2023-03-09
$5.58M
derived: sum of 4 quarters · filed 2023-03-09
2020-12-31$1.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09
$6.81M
derived: sum of 2 quarters · filed 2023-03-09
$6.45M
derived: sum of 3 quarters · filed 2023-03-09
$2.76M
10-K · filed 2023-03-09
2020-09-30$5.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01
$4.84M
derived: sum of 2 quarters · filed 2021-11-01
$1.15M
10-Q · filed 2021-11-01
$3.14M
derived: sum of 4 quarters · filed 2022-03-15
2020-06-30-$362.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
-$4.05M
10-Q · filed 2021-08-06
-$2.07M
derived: sum of 3 quarters · filed 2022-03-15
-$1.19M
derived: sum of 4 quarters · filed 2022-03-15
2020-03-31-$3.69M
10-Q · filed 2021-05-07
-$1.70M
derived: sum of 2 quarters · filed 2022-03-15
-$826.00K
derived: sum of 3 quarters · filed 2022-03-15
$2.44M
derived: sum of 4 quarters · filed 2022-03-15
2019-12-31$1.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15
$2.87M
derived: sum of 2 quarters · filed 2022-03-15
$6.13M
derived: sum of 3 quarters · filed 2022-03-15
$7.66M
10-K · filed 2022-03-15
2019-09-30$878.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$4.14M
derived: sum of 2 quarters · filed 2020-11-05
$5.67M
10-Q · filed 2020-11-05
$6.17M
derived: sum of 4 quarters · filed 2021-03-11
2019-06-30$3.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$4.79M
10-Q · filed 2020-08-06
$5.29M
derived: sum of 3 quarters · filed 2021-03-11
$5.34M
derived: sum of 4 quarters · filed 2021-03-11
2019-03-31$1.53M
10-Q · filed 2020-05-07
$2.03M
derived: sum of 2 quarters · filed 2021-03-11
$2.08M
derived: sum of 3 quarters · filed 2021-03-11
$5.34M
derived: sum of 4 quarters · filed 2021-03-11
2018-12-31$497.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11
$550.00K
derived: sum of 2 quarters · filed 2021-03-11
$3.81M
derived: sum of 3 quarters · filed 2021-03-11
$379.00K
10-K · filed 2021-03-11
2018-09-30$53.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
$3.31M
derived: sum of 2 quarters · filed 2019-11-06
-$118.00K
10-Q · filed 2019-11-06
-$869.00K
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30$3.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
-$171.00K
10-Q · filed 2019-08-07
-$922.00K
derived: sum of 3 quarters · filed 2020-02-27
-$4.75M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31-$3.43M
10-Q · filed 2019-05-09
-$4.18M
derived: sum of 2 quarters · filed 2020-02-27
-$8.01M
derived: sum of 3 quarters · filed 2020-02-27
-$11.60M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31-$751.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
-$4.58M
derived: sum of 2 quarters · filed 2020-02-27
-$8.17M
derived: sum of 3 quarters · filed 2020-02-27
-$5.36M
10-K · filed 2020-02-27
2017-09-30-$3.83M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
-$7.42M
derived: sum of 2 quarters · filed 2018-11-06
-$4.61M
10-Q · filed 2018-11-06
-$6.68M
derived: sum of 4 quarters · filed 2019-02-27
2017-06-30-$3.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
-$776.00K
10-Q · filed 2018-08-07
-$2.85M
derived: sum of 3 quarters · filed 2019-02-27
$355.00K
derived: sum of 4 quarters · filed 2019-02-27
2017-03-31$2.81M
10-Q · filed 2018-05-08
$732.00K
derived: sum of 2 quarters · filed 2019-02-27
$3.94M
derived: sum of 3 quarters · filed 2019-02-27
$4.21M
derived: sum of 4 quarters · filed 2019-02-27
2016-12-31-$2.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
$1.13M
derived: sum of 2 quarters · filed 2019-02-27
$1.40M
derived: sum of 3 quarters · filed 2019-02-27
$1.94M
10-K · filed 2019-02-27
2016-09-30$3.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
$3.48M
derived: sum of 2 quarters · filed 2017-11-02
$4.02M
10-Q · filed 2017-11-02
$3.66M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30$272.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
$807.00K
10-Q · filed 2017-08-03
$453.00K
derived: sum of 3 quarters · filed 2018-02-27
$1.49M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31$535.00K
10-Q · filed 2017-05-04
$181.00K
derived: sum of 2 quarters · filed 2018-02-27
$1.22M
derived: sum of 3 quarters · filed 2018-02-27
$3.19M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31-$354.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$686.00K
derived: sum of 2 quarters · filed 2018-02-27
$2.65M
derived: sum of 3 quarters · filed 2018-02-27
$5.87M
10-K · filed 2018-02-27
2015-09-30$1.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$3.00M
derived: sum of 2 quarters · filed 2016-11-03
$6.22M
10-Q · filed 2016-11-03
$6.39M
derived: sum of 4 quarters · filed 2017-03-02
2015-06-30$1.96M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
$5.18M
10-Q · filed 2016-08-04
$5.36M
derived: sum of 3 quarters · filed 2017-03-02
$6.26M
derived: sum of 4 quarters · filed 2017-03-02
2015-03-31$3.22M
10-Q · filed 2016-05-05
$3.39M
derived: sum of 2 quarters · filed 2017-03-02
$4.29M
derived: sum of 3 quarters · filed 2017-03-02
$5.12M
derived: sum of 4 quarters · filed 2017-03-02
2014-12-31$172.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02
$1.07M
derived: sum of 2 quarters · filed 2017-03-02
$1.90M
derived: sum of 3 quarters · filed 2017-03-02
$3.47M
10-K · filed 2017-03-02
2014-09-30$902.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03
$1.72M
derived: sum of 2 quarters · filed 2015-11-03
$3.30M
10-Q · filed 2015-11-03
$4.00M
derived: sum of 4 quarters · filed 2016-02-23
2014-06-30$822.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04
$2.39M
10-Q · filed 2015-08-04
$3.10M
derived: sum of 3 quarters · filed 2016-02-23
$3.33M
derived: sum of 4 quarters · filed 2016-02-23
2014-03-31$1.57M
10-Q · filed 2015-05-05
$2.28M
derived: sum of 2 quarters · filed 2016-02-23
$2.50M
derived: sum of 3 quarters · filed 2016-02-23
$2.05M
derived: sum of 4 quarters · filed 2016-02-23
2013-12-31$709.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23
$933.00K
derived: sum of 2 quarters · filed 2016-02-23
$480.00K
derived: sum of 3 quarters · filed 2016-02-23
$708.00K
10-K · filed 2016-02-23
2013-09-30$224.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
-$229.00K
derived: sum of 2 quarters · filed 2014-11-10
-$1.00K
10-Q · filed 2014-11-10
-$525.00
10-Q · filed 2013-11-07
$313.83K
derived: sum of 4 quarters · filed 2014-11-10
2013-06-30-$453.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
-$225.00K
10-Q · filed 2014-08-07
-$225.00K
10-Q · filed 2013-08-09
$89.83K
derived: sum of 3 quarters · filed 2014-08-07
-$110.56K
derived: sum of 4 quarters · filed 2014-08-07
2013-03-31$228.00K
10-Q · filed 2014-05-12
$542.83K
derived: sum of 2 quarters · filed 2014-05-12
$342.44K
derived: sum of 3 quarters · filed 2014-05-12
2012-12-31$314.83K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28
$114.44K
derived: sum of 2 quarters · filed 2014-02-28
$702.00K
10-K · filed 2014-02-28
2012-09-30-$200.39K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07
$387.17K
10-Q · filed 2013-11-07
2012-06-30$587.56K
10-Q · filed 2013-08-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
COMPASS Pathways plc (CMPS)$1.812B-4.87
Septerna, Inc. (SEPN)United States$1.783B-63.01
Xencor Inc (XNCR)United States$1.776B-7.33
Zymeworks Inc. (ZYME)United States$1.902B-12.44
Eton Pharmaceuticals, Inc. (ETON)United States$1.701B80.74
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Biohaven Ltd. (BHVN)United States$1.990B-3.83